help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 16, 2006
Endocrinology, doi:10.1210/en.2005-1235
A more recent version of this article appeared on June 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/6/2773    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hiroi, T.
Right arrow Articles by Funae, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hiroi, T.
Right arrow Articles by Funae, Y.

Submitted on September 27, 2005
Accepted on March 9, 2006

Bisphenol A binds to Protein Disulfide Isomerase and inhibits its enzymatic and hormone-binding activities

Toyoko Hiroi*, Kazushi Okada, Susumu Imaoka, Mayuko Osada, and Yoshihiko Funae

Department of Chemical Biology, Osaka City University Medical School, 1-4-3, Asahimachi, Abeno-ku, Osaka 545-8585, Japan

* To whom correspondence should be addressed. E-mail: hiroit{at}nhlbi.nih.gov.

Bisphenol A [2,2-bis (4-hydroxyphenyl) propane, BPA] is a versatile industrial material for plastic products but increasingly being recognized as a pervasive industrial pollutant as well. Accumulating evidence indicates that the environmental contaminant BPA is one of the endocrine disrupting chemicals (EDCs) that can potentially affect humans as well as wildlife adversely. To define the molecular aspects of BPA action, we first investigated the molecules with which it physically interacts. High BPA-binding activity was detected in the P2 membrane fraction prepared from rat brains. As determined by SDS-PAGE analysis, the molecular weight of a BPA-binding protein purified from the rat brain P2 fraction was 53 kDa. The N terminal amino acid sequence of the purified BPA-binding protein was identical to that of the rat protein disulfide isomerase (PDI), which is a multifunctional protein that is critically involved in the folding, assembly, and shedding of many cellular proteins via its isomerase activity, in addition to being considered to function as an intracellular hormone reservoir. The Kd value of BPA binding to recombinant rat PDI was 22.6 ± 6.6 µM. Importantly, the binding activity of 3,5,3'-triiodo-L-thyronine and 17{beta}-estradiol hormones to PDI was competitively inhibited by BPA, in addition to abolishing its isomerase activities. Herein, we report that the ubiquitous and multifunctional protein PDI is a target of BPA and propose that the binding to PDI and the subsequent inhibition of PDI activities might be mechanistically responsible for various BPA actions.


Key words: bisphenol A • endocrine disrupting chemicals • protein disulfide isomerase • thyroid hormones • 17{beta}-estradiol




This article has been cited by other articles:


Home page
Schizophr BullHome page
J. S. Brown Jr
Effects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia
Schizophr Bull, January 31, 2008; (2008) sbm147v1.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society